MDXG
MiMedx Group, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-25
Figures on this page computed 2026-11-08 12:12 UTC
Last close
3.20USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-25
10.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-25
41.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
11.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
17.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-K for 2025, filed 2026-02-25
0.09Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-02-25
- 10-Q for 2025, filed 2026-10-28
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth11.0%56 of 100, above its sector
- Returns on capital41.5%92 of 100, above its sector
- Margins82.6%82 of 100, above its sector
- Price10.0x72 of 100, above its sector
- Safety0.0983 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Sales
171Profit
12,456Shares in issue
133Sales is at 171, Profit is at 12456, Shares in issue is at 133, against 100 in 2016.
Sales is at 171, Profit is at 12456, Shares in issue is at 133, against 100 in 2016.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-25
Sales, where the first year is 100171
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Profit, where the first year is 10012,456
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD
Shares in issue, where the first year is 100133
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001376339-26-000011
- Reported in
- USD